TITLE:
Ondansetron for the Treatment of Cocaine Dependence - 1

CONDITION:
Cocaine-Related Disorders

INTERVENTION:
Ondansetron

SUMMARY:

      The purpose of this study is to assess the efficacy and safety of ondansetron to reduce
      cocaine use in subjects with cocaine dependence.
    

DETAILED DESCRIPTION:

      Double-blind, placebo-controlled, 4-parallel group design to assess the efficacy and safety
      of 3 wide range doses of ondansetron to reduce cocaine use in subjects with cocaine
      dependence and to determine the optimal dose of ondansetron.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 99 Years
Criteria:

        Inclusion Criteria:

        Male/Female, at least 18 yrs of age; DSM-4 diagnosis of cocaine dependence; seeking
        Treatment for cocaine dependence; have ability to understand, having understood and
        provide written consent; females of child bearing potential that use accepted method of
        birth control

        Exclusion Criteria:

        Additional criteria available during screening at the site.
      
